Some studies on the effect of COVID‐19 on the incidence of liver disorders published results, which suggested in the case of COVID‐19 due to the widespread distribution of the main virus receptor called the angiotensin‐converting enzyme 2 (ACE2), the virus could cause a widespread disease with more involvement of extra‐pulmonary organs, especially the liver. This evidence concerns the gene ACE2 and COVID-19.